| Persistence with biologic disease-modifying antirheumatic drugs is moderate in German patients with psoriatic arthritis. |
| The persistence rate depends on the biologic disease-modifying antirheumatic drug considered. |
| Male gender is associated with a lower risk of treatment discontinuation. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.